Harvard Bioscience Names Michael Rossi Chief Financial Officer
Harvard Bioscience, Inc. (HBIO)
Last harvard bioscience, inc. earnings: 2/26 07:15 am
Check Earnings Report
US:NASDAQ Investor Relations:
investor.harvardbioscience.com
Company Research
Source: GlobeNewswire
HOLLISTON, Mass., July 18, 2019 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) announced today that Michael Rossi has been named Chief Financial Officer, effective immediately. Rossi most recently served as Chief Financial Officer of Laborie Medical Technologies, a global medical devices company. Jim Green, Chairman, President and CEO stated, “Mike Rossi’s deep experience in finance, public company accounting, global business operations, and restructuring make him the perfect leader to partner with me to rapidly improve Harvard Bioscience’s financial and operating performance.” Rossi said, “I am honored to join Harvard Bioscience and work with Jim and the company’s talented finance team to execute with urgency and quickly earn the trust of our shareholders.” Rossi, 45, brings to Harvard Bioscience more than 19 years of finance and operational expertise. Prior to serving as Chief Financial Officer of Laborie Medical Technologies, he served as Chief Financial Officer
Show less
Read more
Impact Snapshot
Event Time:
HBIO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HBIO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HBIO alerts
High impacting Harvard Bioscience, Inc. news events
Weekly update
A roundup of the hottest topics
HBIO
News
- In-Vitro and In-Vivo Micro Electrode Array Market to Grow by USD 7 Million (2024-2028), Driven by MEA Applications in Neuroscience Research, with AI Driving Market Transformation - Technavio [Yahoo! Finance]Yahoo! Finance
- Harvard Bioscience, Inc. (HBIO) Q3 2024 Earnings Call Transcript [Seeking Alpha]Seeking Alpha
- Harvard Bioscience Third Quarter 2024 Earnings: Misses Expectations [Yahoo! Finance]Yahoo! Finance
- Harvard Bioscience Inc (HBIO) Q3 2024 Earnings Call Highlights: Navigating Challenges and ... [Yahoo! Finance]Yahoo! Finance
- Harvard Bioscience Announces Third Quarter 2024 Financial ResultsGlobeNewswire
HBIO
Earnings
- 11/7/24 - Miss
HBIO
Sec Filings
- 12/6/24 - Form S-3
- 11/14/24 - Form SC
- 11/8/24 - Form 10-Q
- HBIO's page on the SEC website